Strengthening regulatory capacity for supporting conduct of clinical trials

This section details the eligibility criteria for applicants, the geographical scope of the program, and its overarching objectives. Funding is directed towards legal entities established in EU Member States, associated countries, or specific EDCTP Association member countries, aiming to enhance regulatory capacity for clinical trials across sub-Saharan Africa. The primary goal is to improve health systems and accelerate market authorization processes for new health technologies.

This section outlines the types of projects and activities eligible for funding, focusing on strengthening regulatory systems and technical expertise for clinical trials in sub-Saharan Africa. The program supports activities designed to improve clinical trial oversight, pharmacovigilance, and the market authorization process for health technologies.

This section describes the financial instrument used for this program and the typical funding amounts allocated per project. The funding is provided as grants, supporting Coordination and Support Actions designed to build regulatory capacity.

This section details the essential conditions and requirements for applicants and beneficiaries, covering general admissibility, financial and operational capacities, and specific aspects related to consortium composition and legal frameworks. Proposals are evaluated based on excellence, impact, and implementation quality.

This section outlines the process for submitting applications and how projects are evaluated and selected. The submission and evaluation procedures follow the guidelines set out in the Horizon Europe framework, with a single-stage submission and specific scoring thresholds for evaluation criteria.

This section provides the foundational legal and official documents that govern the "Strengthening regulatory capacity for supporting conduct of clinical trials" funding program, rooted in the broader Horizon Europe framework.